Jun 7, 2024, 02:21
Matt Sagan: Is HER2-negative breast cancer really negative?
Matt Sagan,
of FiBioMed, shared a post on X:“Is HER2-negative breast cancer really negative? Clinical implication of novel assessment method using inPROBE technology. | Journal of Clinical Oncology.
Its great to have an abstract at ASCO2024
But its a dream to հave 2 abstracts at ASCO2024.”
Visit the article website.
Source: Matt Sagan/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31